nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpromazine—ABCB11—Vinblastine—testicular cancer	0.127	0.218	CbGbCtD
Chlorpromazine—BCHE—Cisplatin—testicular cancer	0.0784	0.135	CbGbCtD
Chlorpromazine—ABCB11—Doxorubicin—testicular cancer	0.0778	0.134	CbGbCtD
Chlorpromazine—ADRA1B—vas deferens—testicular cancer	0.0431	0.245	CbGeAlD
Chlorpromazine—CYP2E1—Etoposide—testicular cancer	0.0386	0.0666	CbGbCtD
Chlorpromazine—ABCB1—Dactinomycin—testicular cancer	0.0346	0.0596	CbGbCtD
Chlorpromazine—HTR7—vas deferens—testicular cancer	0.0251	0.143	CbGeAlD
Chlorpromazine—ALB—Methotrexate—testicular cancer	0.0247	0.0425	CbGbCtD
Chlorpromazine—CYP3A4—Ifosfamide—testicular cancer	0.0245	0.0422	CbGbCtD
Chlorpromazine—CYP1A2—Etoposide—testicular cancer	0.0223	0.0385	CbGbCtD
Chlorpromazine—ABCB1—Vinblastine—testicular cancer	0.0217	0.0374	CbGbCtD
Chlorpromazine—CYP2D6—Vinblastine—testicular cancer	0.0204	0.0352	CbGbCtD
Chlorpromazine—ABCB1—Cisplatin—testicular cancer	0.0199	0.0343	CbGbCtD
Chlorpromazine—ABCB1—Etoposide—testicular cancer	0.0195	0.0337	CbGbCtD
Chlorpromazine—ABCB1—Doxorubicin—testicular cancer	0.0133	0.023	CbGbCtD
Chlorpromazine—CYP3A4—Vinblastine—testicular cancer	0.013	0.0224	CbGbCtD
Chlorpromazine—ABCB1—Methotrexate—testicular cancer	0.0129	0.0222	CbGbCtD
Chlorpromazine—CYP2D6—Doxorubicin—testicular cancer	0.0126	0.0216	CbGbCtD
Chlorpromazine—CYP3A4—Etoposide—testicular cancer	0.0117	0.0202	CbGbCtD
Chlorpromazine—HTR7—vein—testicular cancer	0.0107	0.0606	CbGeAlD
Chlorpromazine—CALM2—semen—testicular cancer	0.00921	0.0523	CbGeAlD
Chlorpromazine—CALM1—semen—testicular cancer	0.00917	0.052	CbGeAlD
Chlorpromazine—CYP3A4—Doxorubicin—testicular cancer	0.00799	0.0138	CbGbCtD
Chlorpromazine—HTR2A—vein—testicular cancer	0.00666	0.0378	CbGeAlD
Chlorpromazine—Catatonia—Ifosfamide—testicular cancer	0.00468	0.0326	CcSEcCtD
Chlorpromazine—Ileus paralytic—Vinblastine—testicular cancer	0.00465	0.0323	CcSEcCtD
Chlorpromazine—Megacolon—Methotrexate—testicular cancer	0.00418	0.0291	CcSEcCtD
Chlorpromazine—SMPD1—gonad—testicular cancer	0.00387	0.022	CbGeAlD
Chlorpromazine—Pigmentation disorder—Etoposide—testicular cancer	0.00343	0.0239	CcSEcCtD
Chlorpromazine—SMPD1—female gonad—testicular cancer	0.00315	0.0179	CbGeAlD
Chlorpromazine—DRD4—testis—testicular cancer	0.00314	0.0178	CbGeAlD
Chlorpromazine—SMPD1—testis—testicular cancer	0.00279	0.0158	CbGeAlD
Chlorpromazine—Amenorrhoea—Chlorambucil—testicular cancer	0.0025	0.0174	CcSEcCtD
Chlorpromazine—CALM3—seminal vesicle—testicular cancer	0.00249	0.0141	CbGeAlD
Chlorpromazine—Throat tightness—Etoposide—testicular cancer	0.00234	0.0163	CcSEcCtD
Chlorpromazine—DRD5—female gonad—testicular cancer	0.00233	0.0133	CbGeAlD
Chlorpromazine—Dyskinesia—Chlorambucil—testicular cancer	0.00233	0.0162	CcSEcCtD
Chlorpromazine—ABCB11—testis—testicular cancer	0.00221	0.0125	CbGeAlD
Chlorpromazine—CALM2—embryo—testicular cancer	0.00208	0.0118	CbGeAlD
Chlorpromazine—CALM1—embryo—testicular cancer	0.00207	0.0117	CbGeAlD
Chlorpromazine—SMPD1—lymph node—testicular cancer	0.00202	0.0115	CbGeAlD
Chlorpromazine—CALM2—seminal vesicle—testicular cancer	0.00195	0.0111	CbGeAlD
Chlorpromazine—Extrapyramidal disorder—Ifosfamide—testicular cancer	0.00193	0.0134	CcSEcCtD
Chlorpromazine—Pigmentation disorder—Epirubicin—testicular cancer	0.00192	0.0134	CcSEcCtD
Chlorpromazine—Retinal disorder—Methotrexate—testicular cancer	0.00192	0.0134	CcSEcCtD
Chlorpromazine—Pigmentation disorder—Doxorubicin—testicular cancer	0.00178	0.0124	CcSEcCtD
Chlorpromazine—KCNH2—seminal vesicle—testicular cancer	0.00177	0.01	CbGeAlD
Chlorpromazine—Haemolytic anaemia—Chlorambucil—testicular cancer	0.00176	0.0123	CcSEcCtD
Chlorpromazine—Endocrine disorder—Ifosfamide—testicular cancer	0.00175	0.0122	CcSEcCtD
Chlorpromazine—Amenorrhoea—Ifosfamide—testicular cancer	0.00165	0.0115	CcSEcCtD
Chlorpromazine—BCHE—seminal vesicle—testicular cancer	0.00163	0.00924	CbGeAlD
Chlorpromazine—Dyskinesia—Ifosfamide—testicular cancer	0.00154	0.0107	CcSEcCtD
Chlorpromazine—Infection—Carboplatin—testicular cancer	0.00151	0.0105	CcSEcCtD
Chlorpromazine—Gait disturbance—Ifosfamide—testicular cancer	0.00149	0.0103	CcSEcCtD
Chlorpromazine—Aplastic anaemia—Dactinomycin—testicular cancer	0.00149	0.0103	CcSEcCtD
Chlorpromazine—CALM3—female gonad—testicular cancer	0.00146	0.00829	CbGeAlD
Chlorpromazine—CALM2—gonad—testicular cancer	0.00141	0.00801	CbGeAlD
Chlorpromazine—CALM1—gonad—testicular cancer	0.0014	0.00797	CbGeAlD
Chlorpromazine—ADRA2A—seminal vesicle—testicular cancer	0.00139	0.0079	CbGeAlD
Chlorpromazine—HTR7—gonad—testicular cancer	0.00137	0.00779	CbGeAlD
Chlorpromazine—CYP2E1—seminal vesicle—testicular cancer	0.00136	0.00773	CbGeAlD
Chlorpromazine—Sudden death—Methotrexate—testicular cancer	0.00134	0.00933	CcSEcCtD
Chlorpromazine—Pancytopenia—Chlorambucil—testicular cancer	0.00131	0.00909	CcSEcCtD
Chlorpromazine—CALM3—testis—testicular cancer	0.00129	0.00735	CbGeAlD
Chlorpromazine—HTR2A—embryo—testicular cancer	0.00126	0.00715	CbGeAlD
Chlorpromazine—Body temperature increased—Carboplatin—testicular cancer	0.0012	0.00837	CcSEcCtD
Chlorpromazine—ALB—testis—testicular cancer	0.0012	0.00681	CbGeAlD
Chlorpromazine—Pancytopenia—Vinblastine—testicular cancer	0.0012	0.00833	CcSEcCtD
Chlorpromazine—Jaundice—Chlorambucil—testicular cancer	0.0012	0.00832	CcSEcCtD
Chlorpromazine—CHRM3—female gonad—testicular cancer	0.00117	0.00665	CbGeAlD
Chlorpromazine—Haemolytic anaemia—Ifosfamide—testicular cancer	0.00117	0.00812	CcSEcCtD
Chlorpromazine—CALM2—female gonad—testicular cancer	0.00115	0.00651	CbGeAlD
Chlorpromazine—CALM1—female gonad—testicular cancer	0.00114	0.00648	CbGeAlD
Chlorpromazine—Agranulocytosis—Vinblastine—testicular cancer	0.00105	0.0073	CcSEcCtD
Chlorpromazine—CHRM3—testis—testicular cancer	0.00104	0.0059	CbGeAlD
Chlorpromazine—KCNH2—female gonad—testicular cancer	0.00104	0.00589	CbGeAlD
Chlorpromazine—CALM2—testis—testicular cancer	0.00102	0.00577	CbGeAlD
Chlorpromazine—CALM1—testis—testicular cancer	0.00101	0.00575	CbGeAlD
Chlorpromazine—Pancytopenia—Bleomycin—testicular cancer	0.00101	0.00704	CcSEcCtD
Chlorpromazine—ADRA2A—gonad—testicular cancer	0.00101	0.00571	CbGeAlD
Chlorpromazine—Haemolytic anaemia—Cisplatin—testicular cancer	0.00101	0.007	CcSEcCtD
Chlorpromazine—Cardiac arrest—Ifosfamide—testicular cancer	0.001	0.00697	CcSEcCtD
Chlorpromazine—Urinary retention—Ifosfamide—testicular cancer	0.001	0.00697	CcSEcCtD
Chlorpromazine—Nasal congestion—Cisplatin—testicular cancer	0.000997	0.00693	CcSEcCtD
Chlorpromazine—Dysphagia—Dactinomycin—testicular cancer	0.000993	0.00691	CcSEcCtD
Chlorpromazine—HTR7—testis—testicular cancer	0.000989	0.00561	CbGeAlD
Chlorpromazine—Pancytopenia—Dactinomycin—testicular cancer	0.000943	0.00656	CcSEcCtD
Chlorpromazine—CALM3—lymph node—testicular cancer	0.000939	0.00533	CbGeAlD
Chlorpromazine—Anaphylactoid reaction—Cisplatin—testicular cancer	0.000938	0.00653	CcSEcCtD
Chlorpromazine—DRD2—testis—testicular cancer	0.000935	0.00531	CbGeAlD
Chlorpromazine—KCNH2—testis—testicular cancer	0.000921	0.00523	CbGeAlD
Chlorpromazine—Tremor—Chlorambucil—testicular cancer	0.000898	0.00625	CcSEcCtD
Chlorpromazine—Angioedema—Chlorambucil—testicular cancer	0.000876	0.0061	CcSEcCtD
Chlorpromazine—ALB—lymph node—testicular cancer	0.000869	0.00493	CbGeAlD
Chlorpromazine—Pancytopenia—Ifosfamide—testicular cancer	0.000865	0.00601	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Etoposide—testicular cancer	0.000859	0.00598	CcSEcCtD
Chlorpromazine—Leukopenia—Chlorambucil—testicular cancer	0.000858	0.00597	CcSEcCtD
Chlorpromazine—HTR2A—gonad—testicular cancer	0.000855	0.00486	CbGeAlD
Chlorpromazine—BCHE—testis—testicular cancer	0.000848	0.00481	CbGeAlD
Chlorpromazine—HTR2B—lymph node—testicular cancer	0.000837	0.00475	CbGeAlD
Chlorpromazine—HRH1—female gonad—testicular cancer	0.000832	0.00472	CbGeAlD
Chlorpromazine—Convulsion—Chlorambucil—testicular cancer	0.000831	0.00578	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Cisplatin—testicular cancer	0.000829	0.00577	CcSEcCtD
Chlorpromazine—Agranulocytosis—Dactinomycin—testicular cancer	0.000827	0.00575	CcSEcCtD
Chlorpromazine—ABCB1—embryo—testicular cancer	0.000826	0.00469	CbGeAlD
Chlorpromazine—Hyperglycaemia—Ifosfamide—testicular cancer	0.000821	0.00571	CcSEcCtD
Chlorpromazine—ADRA2A—female gonad—testicular cancer	0.000818	0.00464	CbGeAlD
Chlorpromazine—Glycosuria—Epirubicin—testicular cancer	0.000793	0.00552	CcSEcCtD
Chlorpromazine—Cardiac arrest—Etoposide—testicular cancer	0.000791	0.0055	CcSEcCtD
Chlorpromazine—Leukopenia—Vinblastine—testicular cancer	0.000787	0.00547	CcSEcCtD
Chlorpromazine—Infection—Chlorambucil—testicular cancer	0.000778	0.00541	CcSEcCtD
Chlorpromazine—ABCB1—seminal vesicle—testicular cancer	0.000776	0.0044	CbGeAlD
Chlorpromazine—Blood disorder—Epirubicin—testicular cancer	0.000769	0.00535	CcSEcCtD
Chlorpromazine—Convulsion—Vinblastine—testicular cancer	0.000761	0.0053	CcSEcCtD
Chlorpromazine—Agranulocytosis—Ifosfamide—testicular cancer	0.000757	0.00527	CcSEcCtD
Chlorpromazine—Pancytopenia—Cisplatin—testicular cancer	0.000745	0.00518	CcSEcCtD
Chlorpromazine—HRH1—testis—testicular cancer	0.000738	0.00419	CbGeAlD
Chlorpromazine—CALM2—lymph node—testicular cancer	0.000737	0.00418	CbGeAlD
Chlorpromazine—Glycosuria—Doxorubicin—testicular cancer	0.000734	0.0051	CcSEcCtD
Chlorpromazine—CALM1—lymph node—testicular cancer	0.000734	0.00416	CbGeAlD
Chlorpromazine—Amenorrhoea—Epirubicin—testicular cancer	0.000731	0.00509	CcSEcCtD
Chlorpromazine—Jaundice cholestatic—Epirubicin—testicular cancer	0.000731	0.00509	CcSEcCtD
Chlorpromazine—ADRA2A—testis—testicular cancer	0.000725	0.00412	CbGeAlD
Chlorpromazine—Dysphagia—Etoposide—testicular cancer	0.000719	0.005	CcSEcCtD
Chlorpromazine—Blood disorder—Doxorubicin—testicular cancer	0.000712	0.00495	CcSEcCtD
Chlorpromazine—CYP2E1—testis—testicular cancer	0.000709	0.00403	CbGeAlD
Chlorpromazine—Visual impairment—Ifosfamide—testicular cancer	0.000702	0.00488	CcSEcCtD
Chlorpromazine—Dyskinesia—Epirubicin—testicular cancer	0.000684	0.00475	CcSEcCtD
Chlorpromazine—Pancytopenia—Etoposide—testicular cancer	0.000683	0.00475	CcSEcCtD
Chlorpromazine—Amenorrhoea—Doxorubicin—testicular cancer	0.000676	0.00471	CcSEcCtD
Chlorpromazine—Jaundice cholestatic—Doxorubicin—testicular cancer	0.000676	0.00471	CcSEcCtD
Chlorpromazine—KCNH2—lymph node—testicular cancer	0.000668	0.00379	CbGeAlD
Chlorpromazine—Leukopenia—Bleomycin—testicular cancer	0.000664	0.00462	CcSEcCtD
Chlorpromazine—Gait disturbance—Epirubicin—testicular cancer	0.000658	0.00458	CcSEcCtD
Chlorpromazine—Cough—Bleomycin—testicular cancer	0.000648	0.00451	CcSEcCtD
Chlorpromazine—Aplastic anaemia—Methotrexate—testicular cancer	0.000644	0.00448	CcSEcCtD
Chlorpromazine—Dermatitis contact—Epirubicin—testicular cancer	0.000635	0.00442	CcSEcCtD
Chlorpromazine—CYP2D6—female gonad—testicular cancer	0.000633	0.00359	CbGeAlD
Chlorpromazine—Dyskinesia—Doxorubicin—testicular cancer	0.000632	0.0044	CcSEcCtD
Chlorpromazine—Jaundice—Etoposide—testicular cancer	0.000625	0.00435	CcSEcCtD
Chlorpromazine—Leukopenia—Dactinomycin—testicular cancer	0.00062	0.00431	CcSEcCtD
Chlorpromazine—Body temperature increased—Chlorambucil—testicular cancer	0.000619	0.0043	CcSEcCtD
Chlorpromazine—HTR2A—testis—testicular cancer	0.000617	0.0035	CbGeAlD
Chlorpromazine—BCHE—lymph node—testicular cancer	0.000615	0.00349	CbGeAlD
Chlorpromazine—Gynaecomastia—Methotrexate—testicular cancer	0.000614	0.00427	CcSEcCtD
Chlorpromazine—Constipation—Vinblastine—testicular cancer	0.000613	0.00427	CcSEcCtD
Chlorpromazine—Gait disturbance—Doxorubicin—testicular cancer	0.000609	0.00424	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Bleomycin—testicular cancer	0.000606	0.00421	CcSEcCtD
Chlorpromazine—Visual impairment—Cisplatin—testicular cancer	0.000605	0.00421	CcSEcCtD
Chlorpromazine—Aplastic anaemia—Epirubicin—testicular cancer	0.000603	0.0042	CcSEcCtD
Chlorpromazine—Infection—Bleomycin—testicular cancer	0.000602	0.00419	CcSEcCtD
Chlorpromazine—Agranulocytosis—Etoposide—testicular cancer	0.000598	0.00416	CcSEcCtD
Chlorpromazine—Dermatitis contact—Doxorubicin—testicular cancer	0.000587	0.00409	CcSEcCtD
Chlorpromazine—Angioedema—Ifosfamide—testicular cancer	0.00058	0.00403	CcSEcCtD
Chlorpromazine—Hypersensitivity—Chlorambucil—testicular cancer	0.000577	0.00401	CcSEcCtD
Chlorpromazine—Leukopenia—Ifosfamide—testicular cancer	0.000568	0.00395	CcSEcCtD
Chlorpromazine—Photosensitivity—Methotrexate—testicular cancer	0.000567	0.00395	CcSEcCtD
Chlorpromazine—Hypotension—Bleomycin—testicular cancer	0.000566	0.00394	CcSEcCtD
Chlorpromazine—CYP2D6—testis—testicular cancer	0.000562	0.00319	CbGeAlD
Chlorpromazine—Infection—Dactinomycin—testicular cancer	0.000561	0.0039	CcSEcCtD
Chlorpromazine—ABCB1—gonad—testicular cancer	0.000561	0.00318	CbGeAlD
Chlorpromazine—Aplastic anaemia—Doxorubicin—testicular cancer	0.000558	0.00388	CcSEcCtD
Chlorpromazine—Cough—Ifosfamide—testicular cancer	0.000554	0.00385	CcSEcCtD
Chlorpromazine—Convulsion—Ifosfamide—testicular cancer	0.00055	0.00382	CcSEcCtD
Chlorpromazine—Dyspnoea—Bleomycin—testicular cancer	0.00054	0.00376	CcSEcCtD
Chlorpromazine—HRH1—lymph node—testicular cancer	0.000535	0.00304	CbGeAlD
Chlorpromazine—Photosensitivity—Epirubicin—testicular cancer	0.000531	0.00369	CcSEcCtD
Chlorpromazine—Hypersensitivity—Vinblastine—testicular cancer	0.000528	0.00368	CcSEcCtD
Chlorpromazine—Dermatitis exfoliative—Methotrexate—testicular cancer	0.000528	0.00367	CcSEcCtD
Chlorpromazine—Muscle spasms—Cisplatin—testicular cancer	0.000526	0.00366	CcSEcCtD
Chlorpromazine—ADRA2A—lymph node—testicular cancer	0.000526	0.00298	CbGeAlD
Chlorpromazine—Anaphylactic shock—Ifosfamide—testicular cancer	0.000518	0.0036	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Methotrexate—testicular cancer	0.000515	0.00358	CcSEcCtD
Chlorpromazine—Infection—Ifosfamide—testicular cancer	0.000514	0.00358	CcSEcCtD
Chlorpromazine—Tremor—Cisplatin—testicular cancer	0.000512	0.00356	CcSEcCtD
Chlorpromazine—Dermatitis exfoliative—Epirubicin—testicular cancer	0.000494	0.00344	CcSEcCtD
Chlorpromazine—Photosensitivity—Doxorubicin—testicular cancer	0.000491	0.00342	CcSEcCtD
Chlorpromazine—Leukopenia—Cisplatin—testicular cancer	0.000489	0.00341	CcSEcCtD
Chlorpromazine—Hypotension—Ifosfamide—testicular cancer	0.000484	0.00337	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Epirubicin—testicular cancer	0.000482	0.00335	CcSEcCtD
Chlorpromazine—Muscle spasms—Etoposide—testicular cancer	0.000482	0.00335	CcSEcCtD
Chlorpromazine—Body temperature increased—Bleomycin—testicular cancer	0.000479	0.00333	CcSEcCtD
Chlorpromazine—Hypoglycaemia—Epirubicin—testicular cancer	0.000478	0.00332	CcSEcCtD
Chlorpromazine—Dizziness—Vinblastine—testicular cancer	0.000474	0.0033	CcSEcCtD
Chlorpromazine—Convulsion—Cisplatin—testicular cancer	0.000474	0.0033	CcSEcCtD
Chlorpromazine—Dyspnoea—Ifosfamide—testicular cancer	0.000462	0.00321	CcSEcCtD
Chlorpromazine—Somnolence—Ifosfamide—testicular cancer	0.00046	0.0032	CcSEcCtD
Chlorpromazine—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.000457	0.00318	CcSEcCtD
Chlorpromazine—ABCB1—female gonad—testicular cancer	0.000456	0.00259	CbGeAlD
Chlorpromazine—Leukopenia—Etoposide—testicular cancer	0.000448	0.00312	CcSEcCtD
Chlorpromazine—Body temperature increased—Dactinomycin—testicular cancer	0.000447	0.00311	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Cisplatin—testicular cancer	0.000446	0.0031	CcSEcCtD
Chlorpromazine—Hypersensitivity—Bleomycin—testicular cancer	0.000446	0.0031	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.000446	0.0031	CcSEcCtD
Chlorpromazine—Cardiac arrest—Epirubicin—testicular cancer	0.000443	0.00308	CcSEcCtD
Chlorpromazine—Infection—Cisplatin—testicular cancer	0.000443	0.00308	CcSEcCtD
Chlorpromazine—Constipation—Ifosfamide—testicular cancer	0.000443	0.00308	CcSEcCtD
Chlorpromazine—Hypoglycaemia—Doxorubicin—testicular cancer	0.000442	0.00308	CcSEcCtD
Chlorpromazine—Loss of consciousness—Etoposide—testicular cancer	0.00044	0.00306	CcSEcCtD
Chlorpromazine—Cough—Etoposide—testicular cancer	0.000437	0.00304	CcSEcCtD
Chlorpromazine—Tachycardia—Cisplatin—testicular cancer	0.000436	0.00303	CcSEcCtD
Chlorpromazine—Convulsion—Etoposide—testicular cancer	0.000434	0.00302	CcSEcCtD
Chlorpromazine—Asthma—Methotrexate—testicular cancer	0.000431	0.003	CcSEcCtD
Chlorpromazine—Eosinophilia—Methotrexate—testicular cancer	0.000426	0.00297	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Epirubicin—testicular cancer	0.000426	0.00296	CcSEcCtD
Chlorpromazine—Hypotension—Cisplatin—testicular cancer	0.000417	0.0029	CcSEcCtD
Chlorpromazine—Hypersensitivity—Dactinomycin—testicular cancer	0.000416	0.0029	CcSEcCtD
Chlorpromazine—Cardiac arrest—Doxorubicin—testicular cancer	0.00041	0.00285	CcSEcCtD
Chlorpromazine—Body temperature increased—Ifosfamide—testicular cancer	0.000409	0.00285	CcSEcCtD
Chlorpromazine—Pancytopenia—Methotrexate—testicular cancer	0.000409	0.00285	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Etoposide—testicular cancer	0.000409	0.00284	CcSEcCtD
Chlorpromazine—Infection—Etoposide—testicular cancer	0.000406	0.00283	CcSEcCtD
Chlorpromazine—ABCB1—testis—testicular cancer	0.000404	0.00229	CbGeAlD
Chlorpromazine—Dysphagia—Epirubicin—testicular cancer	0.000403	0.0028	CcSEcCtD
Chlorpromazine—Asthma—Epirubicin—testicular cancer	0.000403	0.0028	CcSEcCtD
Chlorpromazine—Influenza—Epirubicin—testicular cancer	0.000403	0.0028	CcSEcCtD
Chlorpromazine—Tachycardia—Etoposide—testicular cancer	0.000399	0.00278	CcSEcCtD
Chlorpromazine—Eosinophilia—Epirubicin—testicular cancer	0.000399	0.00278	CcSEcCtD
Chlorpromazine—Dyspnoea—Cisplatin—testicular cancer	0.000398	0.00277	CcSEcCtD
Chlorpromazine—Erectile dysfunction—Methotrexate—testicular cancer	0.000397	0.00276	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Doxorubicin—testicular cancer	0.000394	0.00274	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Methotrexate—testicular cancer	0.000393	0.00273	CcSEcCtD
Chlorpromazine—Drowsiness—Methotrexate—testicular cancer	0.000384	0.00267	CcSEcCtD
Chlorpromazine—Pancytopenia—Epirubicin—testicular cancer	0.000383	0.00266	CcSEcCtD
Chlorpromazine—Hypotension—Etoposide—testicular cancer	0.000382	0.00266	CcSEcCtD
Chlorpromazine—Hypersensitivity—Ifosfamide—testicular cancer	0.000381	0.00265	CcSEcCtD
Chlorpromazine—Dysphagia—Doxorubicin—testicular cancer	0.000373	0.00259	CcSEcCtD
Chlorpromazine—Asthma—Doxorubicin—testicular cancer	0.000373	0.00259	CcSEcCtD
Chlorpromazine—Influenza—Doxorubicin—testicular cancer	0.000373	0.00259	CcSEcCtD
Chlorpromazine—Eosinophilia—Doxorubicin—testicular cancer	0.000369	0.00257	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Epirubicin—testicular cancer	0.000368	0.00256	CcSEcCtD
Chlorpromazine—Dyspnoea—Etoposide—testicular cancer	0.000365	0.00254	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Epirubicin—testicular cancer	0.000364	0.00253	CcSEcCtD
Chlorpromazine—Somnolence—Etoposide—testicular cancer	0.000363	0.00253	CcSEcCtD
Chlorpromazine—Drowsiness—Epirubicin—testicular cancer	0.000359	0.0025	CcSEcCtD
Chlorpromazine—Agranulocytosis—Methotrexate—testicular cancer	0.000358	0.00249	CcSEcCtD
Chlorpromazine—Pancytopenia—Doxorubicin—testicular cancer	0.000354	0.00246	CcSEcCtD
Chlorpromazine—Body temperature increased—Cisplatin—testicular cancer	0.000353	0.00245	CcSEcCtD
Chlorpromazine—Jaundice—Epirubicin—testicular cancer	0.00035	0.00244	CcSEcCtD
Chlorpromazine—Constipation—Etoposide—testicular cancer	0.00035	0.00243	CcSEcCtD
Chlorpromazine—Dizziness—Ifosfamide—testicular cancer	0.000342	0.00238	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Doxorubicin—testicular cancer	0.00034	0.00237	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Doxorubicin—testicular cancer	0.000336	0.00234	CcSEcCtD
Chlorpromazine—Agranulocytosis—Epirubicin—testicular cancer	0.000335	0.00233	CcSEcCtD
Chlorpromazine—Drowsiness—Doxorubicin—testicular cancer	0.000332	0.00231	CcSEcCtD
Chlorpromazine—Visual impairment—Methotrexate—testicular cancer	0.000332	0.00231	CcSEcCtD
Chlorpromazine—Hypersensitivity—Cisplatin—testicular cancer	0.000329	0.00229	CcSEcCtD
Chlorpromazine—Jaundice—Doxorubicin—testicular cancer	0.000324	0.00225	CcSEcCtD
Chlorpromazine—Body temperature increased—Etoposide—testicular cancer	0.000323	0.00225	CcSEcCtD
Chlorpromazine—Oedema peripheral—Epirubicin—testicular cancer	0.000318	0.00221	CcSEcCtD
Chlorpromazine—Visual impairment—Epirubicin—testicular cancer	0.000311	0.00216	CcSEcCtD
Chlorpromazine—Agranulocytosis—Doxorubicin—testicular cancer	0.00031	0.00216	CcSEcCtD
Chlorpromazine—Hypersensitivity—Etoposide—testicular cancer	0.000301	0.0021	CcSEcCtD
Chlorpromazine—Oedema peripheral—Doxorubicin—testicular cancer	0.000294	0.00205	CcSEcCtD
Chlorpromazine—ABCB1—lymph node—testicular cancer	0.000293	0.00166	CbGeAlD
Chlorpromazine—Visual impairment—Doxorubicin—testicular cancer	0.000288	0.002	CcSEcCtD
Chlorpromazine—Nervousness—Epirubicin—testicular cancer	0.000273	0.0019	CcSEcCtD
Chlorpromazine—Dizziness—Etoposide—testicular cancer	0.00027	0.00188	CcSEcCtD
Chlorpromazine—Muscle spasms—Epirubicin—testicular cancer	0.00027	0.00188	CcSEcCtD
Chlorpromazine—Leukopenia—Methotrexate—testicular cancer	0.000269	0.00187	CcSEcCtD
Chlorpromazine—Cough—Methotrexate—testicular cancer	0.000262	0.00182	CcSEcCtD
Chlorpromazine—Convulsion—Methotrexate—testicular cancer	0.00026	0.00181	CcSEcCtD
Chlorpromazine—Nervousness—Doxorubicin—testicular cancer	0.000252	0.00176	CcSEcCtD
Chlorpromazine—Syncope—Epirubicin—testicular cancer	0.000252	0.00175	CcSEcCtD
Chlorpromazine—Leukopenia—Epirubicin—testicular cancer	0.000251	0.00175	CcSEcCtD
Chlorpromazine—Muscle spasms—Doxorubicin—testicular cancer	0.00025	0.00174	CcSEcCtD
Chlorpromazine—Loss of consciousness—Epirubicin—testicular cancer	0.000247	0.00172	CcSEcCtD
Chlorpromazine—Cough—Epirubicin—testicular cancer	0.000245	0.0017	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Methotrexate—testicular cancer	0.000245	0.0017	CcSEcCtD
Chlorpromazine—Convulsion—Epirubicin—testicular cancer	0.000243	0.00169	CcSEcCtD
Chlorpromazine—Infection—Methotrexate—testicular cancer	0.000243	0.00169	CcSEcCtD
Chlorpromazine—Dry mouth—Epirubicin—testicular cancer	0.000234	0.00163	CcSEcCtD
Chlorpromazine—Syncope—Doxorubicin—testicular cancer	0.000233	0.00162	CcSEcCtD
Chlorpromazine—Leukopenia—Doxorubicin—testicular cancer	0.000233	0.00162	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Epirubicin—testicular cancer	0.000229	0.00159	CcSEcCtD
Chlorpromazine—Hypotension—Methotrexate—testicular cancer	0.000229	0.00159	CcSEcCtD
Chlorpromazine—Loss of consciousness—Doxorubicin—testicular cancer	0.000228	0.00159	CcSEcCtD
Chlorpromazine—Infection—Epirubicin—testicular cancer	0.000228	0.00158	CcSEcCtD
Chlorpromazine—Cough—Doxorubicin—testicular cancer	0.000227	0.00158	CcSEcCtD
Chlorpromazine—Shock—Epirubicin—testicular cancer	0.000225	0.00157	CcSEcCtD
Chlorpromazine—Convulsion—Doxorubicin—testicular cancer	0.000225	0.00157	CcSEcCtD
Chlorpromazine—Tachycardia—Epirubicin—testicular cancer	0.000224	0.00156	CcSEcCtD
Chlorpromazine—Insomnia—Methotrexate—testicular cancer	0.000222	0.00154	CcSEcCtD
Chlorpromazine—Dyspnoea—Methotrexate—testicular cancer	0.000218	0.00152	CcSEcCtD
Chlorpromazine—Somnolence—Methotrexate—testicular cancer	0.000218	0.00151	CcSEcCtD
Chlorpromazine—Dry mouth—Doxorubicin—testicular cancer	0.000216	0.0015	CcSEcCtD
Chlorpromazine—Hypotension—Epirubicin—testicular cancer	0.000214	0.00149	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000212	0.00148	CcSEcCtD
Chlorpromazine—Infection—Doxorubicin—testicular cancer	0.000211	0.00147	CcSEcCtD
Chlorpromazine—Shock—Doxorubicin—testicular cancer	0.000209	0.00145	CcSEcCtD
Chlorpromazine—Insomnia—Epirubicin—testicular cancer	0.000207	0.00144	CcSEcCtD
Chlorpromazine—Tachycardia—Doxorubicin—testicular cancer	0.000207	0.00144	CcSEcCtD
Chlorpromazine—Dyspnoea—Epirubicin—testicular cancer	0.000204	0.00142	CcSEcCtD
Chlorpromazine—Somnolence—Epirubicin—testicular cancer	0.000204	0.00142	CcSEcCtD
Chlorpromazine—Hypotension—Doxorubicin—testicular cancer	0.000198	0.00138	CcSEcCtD
Chlorpromazine—Constipation—Epirubicin—testicular cancer	0.000196	0.00136	CcSEcCtD
Chlorpromazine—Body temperature increased—Methotrexate—testicular cancer	0.000194	0.00135	CcSEcCtD
Chlorpromazine—Insomnia—Doxorubicin—testicular cancer	0.000192	0.00133	CcSEcCtD
Chlorpromazine—Dyspnoea—Doxorubicin—testicular cancer	0.000189	0.00132	CcSEcCtD
Chlorpromazine—Somnolence—Doxorubicin—testicular cancer	0.000189	0.00131	CcSEcCtD
Chlorpromazine—Constipation—Doxorubicin—testicular cancer	0.000181	0.00126	CcSEcCtD
Chlorpromazine—Body temperature increased—Epirubicin—testicular cancer	0.000181	0.00126	CcSEcCtD
Chlorpromazine—Hypersensitivity—Methotrexate—testicular cancer	0.00018	0.00126	CcSEcCtD
Chlorpromazine—Hypersensitivity—Epirubicin—testicular cancer	0.000169	0.00117	CcSEcCtD
Chlorpromazine—Body temperature increased—Doxorubicin—testicular cancer	0.000168	0.00117	CcSEcCtD
Chlorpromazine—Dizziness—Methotrexate—testicular cancer	0.000162	0.00113	CcSEcCtD
Chlorpromazine—Hypersensitivity—Doxorubicin—testicular cancer	0.000156	0.00109	CcSEcCtD
Chlorpromazine—Dizziness—Epirubicin—testicular cancer	0.000152	0.00105	CcSEcCtD
Chlorpromazine—Dizziness—Doxorubicin—testicular cancer	0.00014	0.000976	CcSEcCtD
Chlorpromazine—CALM1—Signaling by ERBB2—KIT—testicular cancer	0.000114	0.00114	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by PDGF—FGFR3—testicular cancer	0.000113	0.00114	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by PDGF—FGFR3—testicular cancer	0.000113	0.00114	CbGpPWpGaD
Chlorpromazine—CALM1—DAP12 signaling—KIT—testicular cancer	0.000113	0.00114	CbGpPWpGaD
Chlorpromazine—CALM2—DAP12 signaling—KIT—testicular cancer	0.000113	0.00114	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—INSL3—testicular cancer	0.000112	0.00112	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—INSL3—testicular cancer	0.000111	0.00112	CbGpPWpGaD
Chlorpromazine—CALM3—B Cell Activation—FGFR3—testicular cancer	0.000111	0.00112	CbGpPWpGaD
Chlorpromazine—CALM3—DAP12 interactions—KIT—testicular cancer	0.00011	0.00111	CbGpPWpGaD
Chlorpromazine—CALM3—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.00011	0.00111	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by FGFR in disease—KIT—testicular cancer	0.00011	0.00111	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by Wnt—H2AFZ—testicular cancer	0.00011	0.00111	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by NGF—KITLG—testicular cancer	0.00011	0.0011	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by EGFR—KIT—testicular cancer	0.000109	0.0011	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by EGFR in Cancer—KIT—testicular cancer	0.000108	0.00109	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by PDGF—KIT—testicular cancer	0.000108	0.00108	CbGpPWpGaD
Chlorpromazine—CALM1—B Cell Activation—FGFR3—testicular cancer	0.000107	0.00108	CbGpPWpGaD
Chlorpromazine—CALM2—B Cell Activation—FGFR3—testicular cancer	0.000107	0.00108	CbGpPWpGaD
Chlorpromazine—CALM1—DAP12 interactions—KIT—testicular cancer	0.000106	0.00107	CbGpPWpGaD
Chlorpromazine—CALM2—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000106	0.00107	CbGpPWpGaD
Chlorpromazine—CALM2—DAP12 interactions—KIT—testicular cancer	0.000106	0.00107	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by FGFR in disease—KIT—testicular cancer	0.000106	0.00107	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by FGFR in disease—KIT—testicular cancer	0.000106	0.00107	CbGpPWpGaD
Chlorpromazine—CALM1—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000106	0.00107	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—INSL3—testicular cancer	0.000106	0.00107	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by Wnt—H2AFZ—testicular cancer	0.000106	0.00107	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by Wnt—H2AFZ—testicular cancer	0.000106	0.00107	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by NGF—KITLG—testicular cancer	0.000106	0.00107	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by NGF—KITLG—testicular cancer	0.000106	0.00107	CbGpPWpGaD
Chlorpromazine—CALM3—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.000106	0.00107	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by EGFR—KIT—testicular cancer	0.000106	0.00106	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by EGFR—KIT—testicular cancer	0.000106	0.00106	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by EGFR in Cancer—KIT—testicular cancer	0.000105	0.00105	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by EGFR in Cancer—KIT—testicular cancer	0.000105	0.00105	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by PDGF—KIT—testicular cancer	0.000104	0.00105	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by PDGF—KIT—testicular cancer	0.000104	0.00105	CbGpPWpGaD
Chlorpromazine—CALM3—Innate Immune System—BCL10—testicular cancer	0.000104	0.00104	CbGpPWpGaD
Chlorpromazine—CALM2—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.000103	0.00103	CbGpPWpGaD
Chlorpromazine—CALM1—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.000103	0.00103	CbGpPWpGaD
Chlorpromazine—CALM3—B Cell Activation—KIT—testicular cancer	0.000102	0.00102	CbGpPWpGaD
Chlorpromazine—CALM2—Innate Immune System—BCL10—testicular cancer	0.000101	0.00101	CbGpPWpGaD
Chlorpromazine—CALM1—Innate Immune System—BCL10—testicular cancer	0.000101	0.00101	CbGpPWpGaD
Chlorpromazine—CALM3—Adaptive Immune System—BCL10—testicular cancer	9.98e-05	0.001	CbGpPWpGaD
Chlorpromazine—CALM2—B Cell Activation—KIT—testicular cancer	9.85e-05	0.00099	CbGpPWpGaD
Chlorpromazine—CALM1—B Cell Activation—KIT—testicular cancer	9.85e-05	0.00099	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—INSL3—testicular cancer	9.81e-05	0.000986	CbGpPWpGaD
Chlorpromazine—CALM3—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	9.75e-05	0.00098	CbGpPWpGaD
Chlorpromazine—CALM1—Adaptive Immune System—BCL10—testicular cancer	9.66e-05	0.00097	CbGpPWpGaD
Chlorpromazine—CALM2—Adaptive Immune System—BCL10—testicular cancer	9.66e-05	0.00097	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—INSL3—testicular cancer	9.66e-05	0.00097	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—INSL3—testicular cancer	9.64e-05	0.000968	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—INSL3—testicular cancer	9.6e-05	0.000965	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—INSL3—testicular cancer	9.57e-05	0.000962	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—INSL3—testicular cancer	9.48e-05	0.000953	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—INSL3—testicular cancer	9.45e-05	0.00095	CbGpPWpGaD
Chlorpromazine—CALM2—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	9.43e-05	0.000948	CbGpPWpGaD
Chlorpromazine—CALM1—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	9.43e-05	0.000948	CbGpPWpGaD
Chlorpromazine—ABCB11—Metabolism—HPGDS—testicular cancer	8.9e-05	0.000895	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—INSL3—testicular cancer	8.78e-05	0.000883	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by NGF—FGFR3—testicular cancer	8.17e-05	0.000821	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	8.15e-05	0.00082	CbGpPWpGaD
Chlorpromazine—HRH4—Signaling Pathways—H2AFZ—testicular cancer	8.13e-05	0.000817	CbGpPWpGaD
Chlorpromazine—HRH4—Signaling Pathways—STK11—testicular cancer	8.08e-05	0.000812	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—INSL3—testicular cancer	8.02e-05	0.000806	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by NGF—FGFR3—testicular cancer	7.9e-05	0.000794	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by NGF—FGFR3—testicular cancer	7.9e-05	0.000794	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—INSL3—testicular cancer	7.75e-05	0.000779	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—INSL3—testicular cancer	7.75e-05	0.000779	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by NGF—KIT—testicular cancer	7.5e-05	0.000754	CbGpPWpGaD
Chlorpromazine—HRH4—Signaling Pathways—KITLG—testicular cancer	7.48e-05	0.000751	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by NGF—KIT—testicular cancer	7.25e-05	0.000729	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by NGF—KIT—testicular cancer	7.25e-05	0.000729	CbGpPWpGaD
Chlorpromazine—BCHE—Metabolism—HPGDS—testicular cancer	6.52e-05	0.000655	CbGpPWpGaD
Chlorpromazine—ABCB11—Metabolism—STK11—testicular cancer	6.47e-05	0.00065	CbGpPWpGaD
Chlorpromazine—CALM3—Innate Immune System—KITLG—testicular cancer	6.27e-05	0.00063	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling Pathways—H2AFZ—testicular cancer	6.26e-05	0.000629	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling Pathways—STK11—testicular cancer	6.23e-05	0.000626	CbGpPWpGaD
Chlorpromazine—CALM2—Innate Immune System—KITLG—testicular cancer	6.06e-05	0.000609	CbGpPWpGaD
Chlorpromazine—CALM1—Innate Immune System—KITLG—testicular cancer	6.06e-05	0.000609	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—BCL10—testicular cancer	6.05e-05	0.000609	CbGpPWpGaD
Chlorpromazine—CALM3—Adaptive Immune System—KITLG—testicular cancer	6.02e-05	0.000605	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—BCL10—testicular cancer	5.86e-05	0.000589	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—BCL10—testicular cancer	5.86e-05	0.000589	CbGpPWpGaD
Chlorpromazine—CALM1—Adaptive Immune System—KITLG—testicular cancer	5.82e-05	0.000585	CbGpPWpGaD
Chlorpromazine—CALM2—Adaptive Immune System—KITLG—testicular cancer	5.82e-05	0.000585	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling Pathways—KITLG—testicular cancer	5.76e-05	0.000579	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	5.7e-05	0.000573	CbGpPWpGaD
Chlorpromazine—HRH4—Signaling Pathways—FGFR3—testicular cancer	5.56e-05	0.000559	CbGpPWpGaD
Chlorpromazine—SLC22A1—Metabolism—HPGDS—testicular cancer	5.43e-05	0.000546	CbGpPWpGaD
Chlorpromazine—BCHE—Metabolism of proteins—MMP2—testicular cancer	5.14e-05	0.000517	CbGpPWpGaD
Chlorpromazine—HRH4—Signaling Pathways—KIT—testicular cancer	5.1e-05	0.000513	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—HPGDS—testicular cancer	5.02e-05	0.000504	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—H2AFZ—testicular cancer	4.83e-05	0.000486	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—H2AFZ—testicular cancer	4.83e-05	0.000485	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—STK11—testicular cancer	4.81e-05	0.000483	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—STK11—testicular cancer	4.8e-05	0.000482	CbGpPWpGaD
Chlorpromazine—BCHE—Metabolism—STK11—testicular cancer	4.74e-05	0.000476	CbGpPWpGaD
Chlorpromazine—CALM3—Innate Immune System—FGFR3—testicular cancer	4.66e-05	0.000468	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—H2AFZ—testicular cancer	4.62e-05	0.000465	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—HPGDS—testicular cancer	4.6e-05	0.000463	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—STK11—testicular cancer	4.6e-05	0.000462	CbGpPWpGaD
Chlorpromazine—CALM1—Innate Immune System—FGFR3—testicular cancer	4.51e-05	0.000453	CbGpPWpGaD
Chlorpromazine—CALM2—Innate Immune System—FGFR3—testicular cancer	4.51e-05	0.000453	CbGpPWpGaD
Chlorpromazine—CALM3—Adaptive Immune System—FGFR3—testicular cancer	4.47e-05	0.00045	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—KITLG—testicular cancer	4.45e-05	0.000447	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—KITLG—testicular cancer	4.44e-05	0.000446	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—H2AFZ—testicular cancer	4.41e-05	0.000443	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—STK11—testicular cancer	4.39e-05	0.000441	CbGpPWpGaD
Chlorpromazine—CALM2—Adaptive Immune System—FGFR3—testicular cancer	4.33e-05	0.000435	CbGpPWpGaD
Chlorpromazine—CALM1—Adaptive Immune System—FGFR3—testicular cancer	4.33e-05	0.000435	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling Pathways—FGFR3—testicular cancer	4.28e-05	0.00043	CbGpPWpGaD
Chlorpromazine—CALM3—Innate Immune System—KIT—testicular cancer	4.28e-05	0.00043	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—KITLG—testicular cancer	4.25e-05	0.000427	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—HPGDS—testicular cancer	4.23e-05	0.000425	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—HPGDS—testicular cancer	4.2e-05	0.000422	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—H2AFZ—testicular cancer	4.16e-05	0.000418	CbGpPWpGaD
Chlorpromazine—CALM1—Innate Immune System—KIT—testicular cancer	4.14e-05	0.000416	CbGpPWpGaD
Chlorpromazine—CALM2—Innate Immune System—KIT—testicular cancer	4.14e-05	0.000416	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—STK11—testicular cancer	4.14e-05	0.000416	CbGpPWpGaD
Chlorpromazine—CALM3—Adaptive Immune System—KIT—testicular cancer	4.11e-05	0.000413	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—H2AFZ—testicular cancer	4.11e-05	0.000413	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—STK11—testicular cancer	4.08e-05	0.00041	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—HPGDS—testicular cancer	4.06e-05	0.000408	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—HPGDS—testicular cancer	4.06e-05	0.000408	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—KITLG—testicular cancer	4.06e-05	0.000408	CbGpPWpGaD
Chlorpromazine—CALM2—Adaptive Immune System—KIT—testicular cancer	3.97e-05	0.000399	CbGpPWpGaD
Chlorpromazine—CALM1—Adaptive Immune System—KIT—testicular cancer	3.97e-05	0.000399	CbGpPWpGaD
Chlorpromazine—SLC22A1—Metabolism—STK11—testicular cancer	3.94e-05	0.000396	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling Pathways—KIT—testicular cancer	3.93e-05	0.000395	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—KITLG—testicular cancer	3.83e-05	0.000385	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—KITLG—testicular cancer	3.78e-05	0.00038	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—H2AFZ—testicular cancer	3.66e-05	0.000368	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—KITLG—testicular cancer	3.65e-05	0.000367	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—STK11—testicular cancer	3.64e-05	0.000366	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—HPGDS—testicular cancer	3.63e-05	0.000365	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—H2AFZ—testicular cancer	3.58e-05	0.00036	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—H2AFZ—testicular cancer	3.56e-05	0.000358	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—STK11—testicular cancer	3.56e-05	0.000358	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—H2AFZ—testicular cancer	3.54e-05	0.000356	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—H2AFZ—testicular cancer	3.54e-05	0.000356	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—STK11—testicular cancer	3.54e-05	0.000356	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—KITLG—testicular cancer	3.53e-05	0.000355	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—KITLG—testicular cancer	3.53e-05	0.000355	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—H2AFZ—testicular cancer	3.41e-05	0.000342	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—STK11—testicular cancer	3.39e-05	0.00034	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—KITLG—testicular cancer	3.37e-05	0.000339	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—STK11—testicular cancer	3.34e-05	0.000336	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—FGFR3—testicular cancer	3.3e-05	0.000332	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—FGFR3—testicular cancer	3.3e-05	0.000332	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—KITLG—testicular cancer	3.29e-05	0.000331	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—KITLG—testicular cancer	3.27e-05	0.000329	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—KITLG—testicular cancer	3.26e-05	0.000328	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—KITLG—testicular cancer	3.26e-05	0.000328	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—HPGDS—testicular cancer	3.18e-05	0.00032	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—FGFR3—testicular cancer	3.16e-05	0.000318	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—H2AFZ—testicular cancer	3.14e-05	0.000316	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—KITLG—testicular cancer	3.13e-05	0.000315	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—STK11—testicular cancer	3.12e-05	0.000314	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—H2AFZ—testicular cancer	3.09e-05	0.000311	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—H2AFZ—testicular cancer	3.08e-05	0.00031	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—H2AFZ—testicular cancer	3.07e-05	0.000309	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—STK11—testicular cancer	3.07e-05	0.000309	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—STK11—testicular cancer	3.07e-05	0.000309	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—STK11—testicular cancer	3.07e-05	0.000308	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—H2AFZ—testicular cancer	3.06e-05	0.000308	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—STK11—testicular cancer	3.06e-05	0.000307	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—STK11—testicular cancer	3.05e-05	0.000307	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—STK11—testicular cancer	3.05e-05	0.000306	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—H2AFZ—testicular cancer	3.03e-05	0.000305	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—KIT—testicular cancer	3.03e-05	0.000305	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—KIT—testicular cancer	3.03e-05	0.000305	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—H2AFZ—testicular cancer	3.03e-05	0.000304	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—STK11—testicular cancer	3.02e-05	0.000303	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—FGFR3—testicular cancer	3.02e-05	0.000303	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—STK11—testicular cancer	3.01e-05	0.000302	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—HPGDS—testicular cancer	3e-05	0.000301	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—STK11—testicular cancer	2.95e-05	0.000297	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—STK11—testicular cancer	2.95e-05	0.000297	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—KIT—testicular cancer	2.9e-05	0.000292	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—KITLG—testicular cancer	2.89e-05	0.00029	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—FGFR3—testicular cancer	2.84e-05	0.000286	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—KITLG—testicular cancer	2.84e-05	0.000286	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—KITLG—testicular cancer	2.84e-05	0.000285	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—KITLG—testicular cancer	2.83e-05	0.000284	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—KITLG—testicular cancer	2.82e-05	0.000283	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—H2AFZ—testicular cancer	2.81e-05	0.000283	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—FGFR3—testicular cancer	2.81e-05	0.000282	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—STK11—testicular cancer	2.8e-05	0.000281	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—KITLG—testicular cancer	2.79e-05	0.000281	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—KITLG—testicular cancer	2.78e-05	0.00028	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—KIT—testicular cancer	2.77e-05	0.000278	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—FGFR3—testicular cancer	2.71e-05	0.000273	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—STK11—testicular cancer	2.64e-05	0.000265	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—FGFR3—testicular cancer	2.62e-05	0.000264	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—FGFR3—testicular cancer	2.62e-05	0.000264	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—KIT—testicular cancer	2.61e-05	0.000262	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—KITLG—testicular cancer	2.59e-05	0.00026	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—KIT—testicular cancer	2.58e-05	0.000259	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—H2AFZ—testicular cancer	2.57e-05	0.000258	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—STK11—testicular cancer	2.55e-05	0.000256	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—HPGDS—testicular cancer	2.54e-05	0.000255	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—FGFR3—testicular cancer	2.51e-05	0.000252	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—KIT—testicular cancer	2.49e-05	0.00025	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—H2AFZ—testicular cancer	2.48e-05	0.000249	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—H2AFZ—testicular cancer	2.48e-05	0.000249	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—STK11—testicular cancer	2.47e-05	0.000248	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—STK11—testicular cancer	2.47e-05	0.000248	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—FGFR3—testicular cancer	2.45e-05	0.000246	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—FGFR3—testicular cancer	2.43e-05	0.000245	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—FGFR3—testicular cancer	2.42e-05	0.000244	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—FGFR3—testicular cancer	2.42e-05	0.000244	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—KIT—testicular cancer	2.41e-05	0.000242	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—KIT—testicular cancer	2.41e-05	0.000242	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—KITLG—testicular cancer	2.36e-05	0.000237	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—FGFR3—testicular cancer	2.33e-05	0.000234	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—STK11—testicular cancer	2.31e-05	0.000232	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—KIT—testicular cancer	2.3e-05	0.000231	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—KITLG—testicular cancer	2.28e-05	0.000229	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—KITLG—testicular cancer	2.28e-05	0.000229	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—KIT—testicular cancer	2.25e-05	0.000226	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—KIT—testicular cancer	2.23e-05	0.000225	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—KIT—testicular cancer	2.22e-05	0.000224	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—KIT—testicular cancer	2.22e-05	0.000224	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—STK11—testicular cancer	2.18e-05	0.000219	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—FGFR3—testicular cancer	2.15e-05	0.000216	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—KIT—testicular cancer	2.14e-05	0.000215	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—FGFR3—testicular cancer	2.11e-05	0.000212	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—FGFR3—testicular cancer	2.11e-05	0.000212	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—FGFR3—testicular cancer	2.1e-05	0.000211	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—FGFR3—testicular cancer	2.1e-05	0.000211	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—FGFR3—testicular cancer	2.07e-05	0.000209	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—FGFR3—testicular cancer	2.07e-05	0.000208	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—KIT—testicular cancer	1.97e-05	0.000198	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—HPGDS—testicular cancer	1.96e-05	0.000197	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—KIT—testicular cancer	1.94e-05	0.000195	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—KIT—testicular cancer	1.94e-05	0.000195	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—KIT—testicular cancer	1.93e-05	0.000194	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—KIT—testicular cancer	1.92e-05	0.000193	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—FGFR3—testicular cancer	1.92e-05	0.000193	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—KIT—testicular cancer	1.91e-05	0.000191	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—KIT—testicular cancer	1.9e-05	0.000191	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—STK11—testicular cancer	1.85e-05	0.000186	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—KIT—testicular cancer	1.77e-05	0.000177	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—FGFR3—testicular cancer	1.75e-05	0.000176	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—FGFR3—testicular cancer	1.7e-05	0.000171	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—FGFR3—testicular cancer	1.7e-05	0.000171	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—KIT—testicular cancer	1.61e-05	0.000162	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—KIT—testicular cancer	1.56e-05	0.000157	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—KIT—testicular cancer	1.56e-05	0.000157	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—STK11—testicular cancer	1.42e-05	0.000143	CbGpPWpGaD
